| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 17.05.
| Avanir Pharmaceuticals CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript) | | 3 | Seeking Alpha |
| 16.05.
| Reflections on Arena's AdComm: What's Ahead for Arena, Vivus, Avanir | | 10 | Motley Fool |
| 10.05.
| Hot Stock: AVANIR Pharmaceuticals, Shares Gain 7.4% | | 7 | SmarTrend |
| 10.05.
| Avanir Pharmaceuticals' Presents at Deutsche Bank Securities Annual Health Care Conference (Transcript) | | 3 | Seeking Alpha |
| 09.05.
| Avanir Pharmaceuticals Catches Analysts Sleeping Again | | 4 | Motley Fool |
| 08.05.
| Avanir Pharmaceuticals Q2 Loss Widens | | 47 | AFX News |
| WASHINGTON (dpa-AFX) - Avanir Pharmaceuticals, Inc. (AVNR) reported a
second-quarter net loss of $17.0 million or $0.13 per share, wider than the net
loss of $14.5 million or $0.12 per share...
Mehr lesen zu:
Avanir Pharmaceuticals Q2 Loss Widens | |
| 08.05.
| Avanir Pharmaceuticals' CEO Discusses F2Q2012 Results - Earnings Call Transcript | | 3 | Seeking Alpha |
| 08.05.
| Avanir Pharmaceuticals Reports Fiscal 2012 Second Quarter Financial and Business Results | | 15 | PR Newswire |
| ALISO VIEJO, Calif., May 8, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today reported financial results for the three and six months ended March 31, 2012.
Quarterly...
Mehr lesen zu:
Avanir Pharmaceuticals Reports Fiscal 2012 Second Quarter Financial and Business Results | |
| 04.05.
| Avanir Pharmaceuticals FY Q2 Earnings Preview: Meet, Beat Or Miss? | | 3 | Seeking Alpha |
| 01.05.
| Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Second Quarter Financial Results And Conference Call | | 14 | PR Newswire |
| ALISO VIEJO, Calif., May 1, 2012 /PRNewswire/ --Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) will report financial results for the quarter ended March 31, 2012 before market open on Tuesday May 8,...
Mehr lesen zu:
Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Second Quarter Financial Results And Conference Call | |
| 01.05.
| Avanir Pharmaceuticals To Present at Three Conferences In May | | 11 | PR Newswire |
| ALISO VIEJO, Calif., May 1, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at three conferences...
Mehr lesen zu:
Avanir Pharmaceuticals To Present at Three Conferences In May | |
| 20.04.
| AVANIR Pharmaceuticals has the Lowest EPS Growth in the Pharmaceuticals Industry | | 4 | SmarTrend |
| 17.04.
| Avanir Pharmaceuticals to Present Data at the American Academy of Neurology Annual Meeting | | 27 | PR Newswire |
| ALISO VIEJO, Calif., April 17, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that data from clinical research activities will be highlighted at...
Mehr lesen zu:
Avanir Pharmaceuticals to Present Data at the American Academy of Neurology Annual Meeting | |
| 10.04.
| Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference | | 17 | PR Newswire |
| ALISO VIEJO, Calif., April 10, 2012 /PRNewswire/ --Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the Future...
Mehr lesen zu:
Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference | |
| 10.04.
| AVANIR Pharmaceuticals has the Highest Enterprise Value to Sales Ratio in the Pharmaceuticals Industry | | 2 | SmarTrend |
| 22.03.
| TREAT Act Poised to Revolutionize the Biotechnology Industry / Five Star Equities Provides Stock Research on Avanir Pharmaceuticals & Zalicus | | 58 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 03/22/12 -- In recent years, smaller biotechnology companies have received less funding from venture capitalists than in years past. According to the Biotechnology...
Mehr lesen zu:
TREAT Act Poised to Revolutionize the Biotechnology Industry / Five Star Equities Provides Stock Research on Avanir Pharmaceuticals & Zalicus | |
| 16.03.
| Avanir Pharmaceuticals Announces Appointment of Rohan Palekar as Chief Commercial Officer | | 41 | PR Newswire |
| ALISO VIEJO, Calif., March 16, 2012 /PRNewswire/ --Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the appointment of Rohan Palekar to the position of senior vice president...
Mehr lesen zu:
Avanir Pharmaceuticals Announces Appointment of Rohan Palekar as Chief Commercial Officer | |
| 12.03.
| Cell Therapeutics and Avanir Pharmaceuticals Look to Make Headway in Strengthening Biotech Industry / The Paragon Report Provides Equity Research on Cell Therapeutics & Avanir Pharmaceuticals | | 76 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 03/12/12 -- The biotechnology industry has been on an impressive run this year as companies -- both large and small -- show impressive growth. The iShares Nasdaq Biotechnology...
Mehr lesen zu:
Cell Therapeutics and Avanir Pharmaceuticals Look to Make Headway in Strengthening Biotech Industry / The Paragon Report Provides Equity Research on Cell Therapeutics & Avanir Pharmaceuticals | |
| 01.03.
| Avanir Pharmaceuticals to Participate in Two Conferences in March | | 44 | PR Newswire |
| ALISO VIEJO, Calif., March 1, 2012 /PRNewswire/ --Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will participate in the following conferences in...
Mehr lesen zu:
Avanir Pharmaceuticals to Participate in Two Conferences in March | |
| 29.02.
| Avanir And Concert Sign License Deal For Deuterium-modified Dextromethorphan | | 69 | AFX News |
| WASHINGTON (dpa-AFX) - Avanir Pharmaceuticals Inc. (AVNR) and Concert
Pharmaceuticals, Inc. announced that they have entered into an exclusive license
agreement that provides Avanir worldwide...
Mehr lesen zu:
Avanir And Concert Sign License Deal For Deuterium-modified Dextromethorphan | |
